Why Trading Biotech and Pharma Stocks is a Mistake!
<p>Hedge Funds and Investment Banks have literal teams of PhD Biochemists as Research Analysts and Portfolio Managers that have studied chemical compounds for years (trust me I know some of these individuals — you do NOT want to compete with them in a zero sum game that is the Stock Market).</p>
<p>Pharma and Biotech Stocks have Current Drug Portfolios and Pipeline Drugs that are going through phases of approval i.e., ‘P1’, ‘P2’, and ‘P3’ approvals with FDA.</p>
<p><a href="https://medium.com/@raiyhan/why-trading-biotech-and-pharma-stocks-is-a-mistake-9a621671a85c"><strong>Read More</strong></a></p>